Supernus Pharmaceuticals, Inc. (SUPN)

52.12 +0.67 (+1.30%) USD  |  NASDAQ  |  May 07, 11:56
More

Supernus Pharmaceuticals Free Cash Flow : 82.24M for March 31, 2026

Free Cash Flow Chart

View Free Cash Flow for SUPN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Biogen, Inc. 2.316B
Corcept Therapeutics, Inc. 119.79M
BridgeBio Pharma, Inc. -455.50M
Cytokinetics, Inc. -548.92M
Oncotelic Therapeutics, Inc. -1.383M

Free Cash Flow Related Metrics

Cash from Operations (Quarterly) 66.52M
Cash from Investing (Quarterly) -19.22M
Cash from Financing (Quarterly) 9.115M
Free Cash Flow Per Share (Quarterly) 1.154
Free Cash Flow to Equity (Quarterly) 66.60M
Free Cash Flow to Firm (Quarterly) 66.52M
Free Cash Flow Yield 2.77%